We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA PANEL RECOMMENDS AGAINST GENTA CANCER DRUG
FDA PANEL RECOMMENDS AGAINST GENTA CANCER DRUG
May 3, 2004
An FDA advisory panel yesterday recommended that the agency reject a new drug application (NDA) for the cancer drug Genasense, saying the clinical trial data submitted in support of the application did not offer substantial evidence of the drug’s efficacy.